Expanding Drug Delivery Embecta's strategic focus on expanding into drug delivery and chronic care presents opportunities to collaborate with pharmaceutical companies seeking integrated delivery solutions and to develop new product offerings tailored to evolving treatment protocols.

Digital and Tech Adoption The company's utilization of advanced technology such as Google Cloud and compliance standards like ISO/IEC 27001 indicates openness to digital transformation projects, creating scope for cybersecurity and cloud service partnerships.

Cost Optimization Initiatives Recent restructuring efforts aimed at cost reduction and operational efficiency open avenues to offer solutions that support manufacturing automation, ERP enhancements, or supply chain optimization tailored for medical device production.

Market Diversification Embecta's shift away from insulin patch pumps towards core insulin delivery and adjacent markets suggests opportunities to introduce innovative components, complementary therapies, or new interface technologies to enhance product lines.

Growth through Partnerships The company's emphasis on pharma collaborations and strategic acquisitions signals an openness to partnership opportunities, especially with firms focusing on novel diabetes management devices, digital health integration, or expanding into GLP-1 therapies.